Literature DB >> 6214878

Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts.

B D Kahan, C T Van Buren, S N Lin, Y Ono, G Agostino, S J LeGrue, M Boileau, W D Payne, R H Kerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6214878     DOI： 10.1097/00007890-198207000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  16 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  The development of clinical renal transplantation.

Authors:  T E Starzl
Journal:  Am J Kidney Dis       Date:  1990-12       Impact factor: 8.860

Review 3.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 4.  Steps in immunosuppression for renal transplantation.

Authors:  T E Starzl; J T Rosenthal; T R Hakala; S Iwatsuki; B W Shaw; G B Klintmalm
Journal:  Kidney Int Suppl       Date:  1983-05       Impact factor: 10.545

Review 5.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

6.  Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids.

Authors:  T E Starzl; T R Hakala; J T Rosenthal; S Iwatsuki; B W Shaw
Journal:  Surg Gynecol Obstet       Date:  1982-06

7.  Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.

Authors:  G J Burckart; R Venkataramanan; R J Ptachcinski; T E Starzl; B P Griffith; T R Hakala; J T Rosenthal; R L Hardesty; S Iwatsuki; J Brady
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

8.  Renal function in rats treated with cyclosporin following unilateral nephrectomy.

Authors:  P H Whiting; J I Duncan; M P Gavin; S D Heys; J G Simpson; S K Asfar; A W Thomson
Journal:  Br J Exp Pathol       Date:  1985-10

Review 9.  Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

Authors:  S Noble; A Markham
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.